You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (9) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Remove Biologicals filter Biologicals (9)
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (27) Apply Complementary medicines filter
- Remove Cosmetics filter Cosmetics (2)
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (23) Apply Legislation filter
- Listed medicines (3) Apply Listed medicines filter
- Manufacturing (12) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (53) Apply Medical devices/IVDs filter
- Medicinal cannabis (2) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- OTC medicines (40) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (28) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (46) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (7) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Draft standards for faecal microbiota transplant (FMT) products
Closed on 31 January 2020
Options for the regulation of Faecal Microbiota Transplantation materials
Closed on 15 March 2019
Nomenclature of Biological Medicines
Closed on 8 September 2017
Consultation on adoption of a European Union guideline in Australia
Closed on 16 December 2016
Guidance on biovigilance responsibilities of sponsors of biologicals
Closed on 16 December 2016
Guidance on risk management plans for medicines and biologicals
Closed on 16 December 2016
Guidance on variations to biologicals included in the Register
Closed on 25 November 2016
Regulation of autologous cell and tissue products and proposed consequential changes to the classification of biologicals
Closed on 6 October 2016
Joint TGA/PBD discussion paper on Similar Biological Medicinal Products (SBMPs)
Closed on 8 September 2010
Review of the regulation of products at the interface between cosmetics and therapeutic goods
Closed on 3 August 2005